$BDX

The Medical Supply Chain Security Act (HR6049) aims to bolster domestic medical supply production and reduce reliance on foreign sources. This will directly benefit U.S.-based medical device and pharmaceutical manufacturers, increasing their market share and contract opportunities. Healthcare providers will also see improved supply stability.

The SEPSIS Act, sponsored by Senate Majority Leader Schumer, signals increased federal focus and funding for sepsis research and treatment. This directly benefits companies providing diagnostic tools, medical devices, and therapeutic solutions for sepsis.